Skip to main content

Table 1 Baseline measures. Data are weighted for the sampling scheme.

From: Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care

  None of the psychiatric disorders Anxiety or depressive disorder Somatoform disorders, undifferentiated * Somatoform disorder, others** Total
Patient characteristics (questionnaire) (n = 274) (n = 51) (n = 94) (n = 12) (n = 400)
Gender (men) 28% 28% 20% 17% 28%
Age:      
   - 65 and over 23% 4% 4% 0% 17%
   - mean (se) 52 (0.8) 43 (1.3) 45 (1.0) 44 (2.8) 49 (0.6)
Physical symptoms (PSC total score) 4 (0.3) 11 (1.1) 10 (0.7) 15 (3.0) 6 (0.3)
Distress symptoms (HADS total score) 8 (0.3) 21 (1.1) 15 (0.8) 20 (2.3) 11 (0.4)
Health status      
Somatic morbidity:      
- CIRS somatic morbidity score 6.8 (0.2) 7.5 (0.5) 7.0 (0.4) 6.8 (0.9) 6.9 (0.2)
- Number of unique somatic prescriptions (FP or other) 5.0 (0.3) 6.3 (0.7) 6.3 (0.5) 5.7 (0.9) 5.4 (0.2)
Psychiatric morbidity:      
- CIRS psychiatric severity score 0.4 (0.0) 1.5 (0.1) 1.0 (0.1) 1.7 (0.2) 0.6 (0.0)
Use of anxiolytics (self report at time of interview) 3% 14% 15% 8% 6%
Use of antidepressants (self report at time of interview) 5% 37% 25% 42% 12%
  1. * Undifferentiated somatoform disorders included chronic pain disorders.
  2. ** Other somatoform disorders: hypochondriasis, somatization disorder and conversion disorder.